Wire News
New drug for kidney transplant recipients effective in humans
Initial results of a study conducted at 100 centers worldwide indicate that belatacept, a first-in-class co-stimulation blocker can prevent the immune system rejecting new organs. The results also suggest that it may provide similar patient and graft surv ...
Source:
Wiley-Blackwell
Wednesday, February 17, 2010